5th Annual Advances in Immuno-Oncology Congress

21 – 22 May 2020| London, UK

 

Oxford Global is proud to present the 5th Annual Advances in Immuno-Oncology Congress taking place on 21 – 22 May 2020 in London, UK. A revamped programme for 2020 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic. Over 60 presentations will provide the latest case studies across key therapeutic areas such as T-cell therapy, bispecific antibodies, cancer vaccines, checkpoint inhibitors and microbiome-based therapeutics. Further talks look at genomic strategies for cancer immunotherapy, as well as personalising cancer treatments.  

 

View Agenda: https://bit.ly/2uT96YD 

 

Key Speakers include Directors and VPs from Merus, Crescendo Biologics, Elstar Therapeutics, Amgen, AstraZeneca and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. It will bring together over 350 senior industry experts and key opinion leaders in immuno-oncology.

Go Social: Join our Advances in Immunotherapy Group on LinkedIn, follow us on Twitter @ImmunoOncConf and join the congress conversation on #IMMUNOUK20

For more information about the event, please contact Danielle Dalby at d.dalby@oxfordglobal.co.uk or the Website: https://bit.ly/2QW5Xjq